Clever Leaves Reschedules Fourth Quarter and Full Year 2022 Conference Call to Thursday, March 30, 2023 at 5:00 p.m. ET

Clever Leaves Reschedules Fourth Quarter and Full Year 2022 Conference Call to Thursday, March 30, 2023 at 5:00 p.m. ET

TOCANCIPÁ, Colombia, March 17, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it will be rescheduling its previously planned conference call on Thursday, March 23, 2023 at 5:00 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2022. The rescheduling is due to additional time needed to finalize the audit of its 2022 financial statements.

The Company’s rescheduled fourth quarter and full year 2022 conference call will be held on Thursday, March 30, 2023 at 5:00 p.m. Eastern time. The Company will provide its financial results in a press release prior to the conference call.

Clever Leaves management will host the conference call, followed by a question-and-answer session.

Conference Call Date: March 30, 2023

Time: 5:00 p.m. Eastern time

Toll-free dial-in number: 1-855-238-2333

International dial-in number: 1-412-317-5222

Conference ID: 10175028

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at (949) 574-3860.

The conference call will be broadcast live and available for replay

here

.

A telephonic replay of the conference call will also be available after 8:00 p.m. Eastern time on the same day through April 4, 2023.

Toll-free replay number: 1-844-512-2921

International replay number: 1-412-317-6671

Replay ID: 10175028


About Clever Leaves Holdings Inc.

Clever Leaves is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products ​in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications. We announce material information to the public through a variety of means, including filings with the SEC, press releases, public conference calls, and our website (

HOME



). We use these channels, as well as social media, including our Twitter account (

@clever_leaves

), and our LinkedIn page (

https://www.linkedin.com/company/clever-leaves

), to communicate with investors and the public about our Company, our products, and other matters. Therefore, we encourage investors, the media, and others interested in our Company to review the information we make public in these locations, as such information could be deemed to be material information. Information on or that can be accessed through our websites or these social media channels is not part of this release, and references to our website addresses and social media channels are inactive textual references only.


Clever Leaves Investor Inquiries:


Cody Slach or Jackie Keshner

Gateway Group, Inc.

+1-949-574-3860


CLVR@gatewayir.com


Clever Leaves Press Contacts:


Rich DiGregorio

KCSA Strategic Communications

+1-856-889-7351


cleverleaves@kcsa.com


Clever Leaves Commercial Inquiries:


Andrew Miller

Vice President Sales – EMEA, North America, and Asia-Pacific

+1-416-817-1336


andrew.miller@cleverleaves.com


Primary Logo

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *